EDMONTON, Alberta — February 15, 2019. Fedora Pharmaceuticals Inc. is pleased to recognize the appointment of Dr. Renata Jankowska as an Adjunct Professor in the Faculty of Pharmacy and Pharmaceutical Sciences at the University of Alberta, effective February 15, 2019, through December 31, 2022.
This appointment reflects Dr. Jankowska's scientific expertise, commitment to research excellence, and ongoing contributions to the advancement of pharmaceutical and antimicrobial research. Through this role, Dr. Jankowska will collaborate with faculty researchers and students to support innovative scientific initiatives and strengthen the connection between academic research and industry-driven drug discovery.
As an Adjunct Professor, Dr. Jankowska's primary focus will be on research collaboration, fostering opportunities for knowledge exchange and supporting the development of future scientists within Alberta's life sciences ecosystem.
Dr. Jankowska has been an important contributor to Fedora Pharmaceuticals' research and development programs. Her appointment further reinforces Fedora's commitment to collaborating with leading academic institutions and advancing scientific innovation through partnerships that accelerate the discovery and development of novel therapeutics.
Renata's appointment recognizes the depth of scientific expertise that she brings to both our organization and the broader research community. We are proud to see her contributions acknowledged by one of Canada's leading research universities, and we look forward to the continued impact of her collaborative work.
Christopher G. Micetich, President and Chief Executive Officer of Fedora Pharmaceuticals Inc.
The University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences is internationally recognized for its contributions to pharmaceutical research, education, and innovation. Through adjunct appointments such as this, industry and academic leaders work together to address important healthcare challenges and create new opportunities for scientific advancement.
Dr. Jankowska's appointment highlights the strong relationship between Fedora Pharmaceuticals and the University of Alberta and underscores the company's ongoing commitment to fostering research excellence, innovation, and talent development in the life sciences sector.
About Dr. Renata Jankowska
Dr. Renata Jankowska is a pharmaceutical scientist whose work has contributed to research programs focused on antimicrobial drug discovery and development. Her expertise and collaborative approach have supported numerous scientific initiatives involving both industry and academic partners. Through her work with Fedora Pharmaceuticals and the University of Alberta, Dr. Jankowska continues to contribute to the advancement of innovative solutions addressing critical healthcare challenges.
About Fedora Pharmaceuticals
Fedora Pharmaceuticals Inc. is a biotechnology company dedicated to the discovery and development of novel antimicrobial agents to address the growing challenge of antimicrobial resistance. Based in Edmonton, Alberta, Fedora works with academic institutions, industry partners, and scientific collaborators to advance innovative therapies targeting multi-drug-resistant pathogens.
